For all the progress made in fighting cancer, it still kills 10 million people a year, and some types remain especially hard to detect and treat. Pancreatic cancer, for instance, is nearly always fatal. A new clinical-trial platform could change that by aligning institutions that typically compete against one another.
For all the progress made in fighting cancer, it still kills 10 million people a year, and some types remain especially hard to detect and treat. Pancreatic cancer, for instance, is nearly always fatal. A new clinical-trial platform could change that by aligning institutions that typically compete against one another. To find out more, check out the podcasts from which . . .
For all the progress made in fighting cancer, it still kills 10 million people a year, and some types remain especially hard to detect and treat. Pancreatic cancer, for instance, is nearly always fatal. A new clinical-trial platform could change that by aligning institutions that typically compete against one another. To find out more, check out the podcasts from which . . .
Follow this show
Follow this show
Follow this show
You want to listen to Freakonomics Radio? That’s great! Most people use a podcast app on their smartphone. It’s free (with the purchase of a phone, of course). Looking for more guidance? We’ve got you covered.
Stay up-to-date on all our shows. We promise no spam.
